Good place to work. great work life balance, a culture that values and respects employees but this is changing... - Assoc. Director, Regulatory Affairs Biogen Employee Review

Has transformed into a highly bureaucratic organization. New management at the top is encouraging this and is rapidly turning the company into a highly silo'ed and bureaucratic organization where titles and political astuteness are more important and better recognized than intellectual contributions. Company is becoming more of a political warfare zone rather than a place to work. Something needs to be done now. New linear organizational structure limits potential for career growth. People in critical/responsible roles have limited to no experience in the job. Others who do the work thus suffer. No leadership from middle management. They are just stuck up on titles. Consider your options carefully before accepting an offer from the Regulatory Affairs CMC group. Reg CMC management lack fundamental technical knowledge and thus even simple decision making takes for ever and many departmental policies/decisions seem to lack clear rationale. Company relying heavily on prior management decisions that are only now beginning to finally bring results. No evidence of leadership from new management who seem not very focussed on securing the future but for short term decisions to boost stock price. The value addition to the organization in firing hundreds of employees, cutting core therapeutic areas and new culture of "NEXT" remain questionable. Narrow pipeline or products are disease focussed rather than therapeutic area focussed.